Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05143840
What this trial is testing

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia, Chronic PhaseAdult CMLLeukemia, Myeloid+1 more
University of Alabama at Birmingham 100
Testing effectiveness (Phase 2)Study completedNCT01912274
What this trial is testing

Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Helsinn Healthcare SA 50
Testing effectiveness (Phase 2)Study completedNCT00363649
What this trial is testing

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Large-scale testing (Phase 3)Study completedNCT00931138
What this trial is testing

Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association 420
Not applicableEnded earlyNCT00594308
What this trial is testing

In-Vivo Activated T-Cell Depletion to Prevent GVHD

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Indiana University 10
Testing effectiveness (Phase 2)Ended earlyNCT05358808
What this trial is testing

ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
TC Biopharm 16
Early research (Phase 1)Active Not RecruitingNCT05001828
What this trial is testing

Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, Adult
Polaris Group 38
Not applicableLooking for participantsNCT06724536
What this trial is testing

Interaction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CML

Who this might be right for
Leukemia,Myeloid, Chronic
Carmen Fava 100
Not applicableStudy completedNCT01321385
What this trial is testing

Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 97
Not applicableStudy completedNCT00478985
What this trial is testing

Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia

Who this might be right for
Myeloid Leukemia, Chronic
University Hospital, Bordeaux 100
Early research (Phase 1)Study completedNCT00422825
What this trial is testing

Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib

Who this might be right for
Healthy
Novartis Pharmaceuticals 16
Large-scale testing (Phase 3)Study completedNCT00110955
What this trial is testing

Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

Who this might be right for
AnemiaNon-Myeloid Malignancies
Amgen 391
Not applicableNot Yet RecruitingNCT05602168
What this trial is testing

Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance

Who this might be right for
Hematologic Cancer
Institut Paoli-Calmettes 400
Early research (Phase 1)Study completedNCT02782468
What this trial is testing

Pevonedistat in Adult East Asian Participants

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Millennium Pharmaceuticals, Inc. 23
Testing effectiveness (Phase 2)Looking for participantsNCT03418038
What this trial is testing

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+5 more
Mayo Clinic 80
Testing effectiveness (Phase 2)Study completedNCT00129740
What this trial is testing

Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)

Who this might be right for
Leukemia, Myelogenous, Chronic
M.D. Anderson Cancer Center 148
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00125840
What this trial is testing

Clofarabine in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsLeukemia, Lymphocytic, Acute, PediatricLeukemia, Lymphocytic, Acute, Adult+3 more
Genzyme, a Sanofi Company
Large-scale testing (Phase 3)Study completedNCT01511289
What this trial is testing

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL Positive+3 more
Il-Yang Pharm. Co., Ltd. 242
Testing effectiveness (Phase 2)Study completedNCT02092324
What this trial is testing

Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

Who this might be right for
Atypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Neutrophilic Leukemia
OHSU Knight Cancer Institute 51
Next Page